Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07312669 · ClinicalTrials.gov registry record
ROP Check Database Premature Infant Outcomes
A clinical trial of Retinopathy of Prematurity (ROP), sponsored by Alaska Blind Child Discovery.
- Completed
- Registry status
- 7,070
- Enrollment target
- 1
- Study location
NCT07312669: Completed study of Retinopathy of Prematurity (ROP), sponsored by Alaska Blind Child Discovery.
NCT07312669 is a study of Retinopathy of Prematurity (ROP) that has completed, run by Alaska Blind Child Discovery. The registered enrollment target is 7,070 participants, above the 203-participant average among 3 other Retinopathy of Prematurity (ROP) trials with a reported enrollment target (3383% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07312669, a study of Retinopathy of Prematurity (ROP), has completed, sponsored by Alaska Blind Child Discovery.
- COMPLETED
- Registry status
- 7,070 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observation of multi-centered care of infants covered by ROP Check cloud-based database is to compare demographic and clinical risk factors to evaluate and improve vision-protecting guidelines.
Primary Outcome
Type 1 ROP
Conditions Studied
Study Locations (1)
Alaska
- Alaska Children's EYE & Strabismus - Anchorage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,070 participants |
| Start Date | 2010-01-01 |
| Est. Completion | 2022-12-31 |
What the finished NCT07312669 record still lists
NCT07312669 is an observational study that tracks outcomes without assigning an intervention. Its 7,070 participants enrollment target places it among the larger protocols in the corpus, above the 203-participant average among 3 other Retinopathy of Prematurity (ROP) trials with a reported enrollment target (3383% higher).
The record links to 1 condition, with Retinopathy of Prematurity (ROP) appearing as the primary indexed condition, and to 0 interventions.
NCT07312669 reports a single indexed study location in Alaska.
Frequently Asked Questions
What is clinical trial NCT07312669 about?
NCT07312669 is a clinical study titled "ROP Check Database Premature Infant Outcomes". The goal of this observation of multi-centered care of infants covered by ROP Check cloud-based database is to compare demographic and clinical risk factors to evaluate and improve vision-protecting guidelines.
What is the current status of trial NCT07312669?
This trial is currently completed. The enrollment target is 7,070 participants. The study started on 2010-01-01. Estimated completion is 2022-12-31.
What conditions does trial NCT07312669 study?
This clinical trial studies the following conditions: Retinopathy of Prematurity (ROP).
Who is sponsoring clinical trial NCT07312669?
This trial is sponsored by Alaska Blind Child Discovery, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07312669 being conducted?
This trial has 1 study location across Alaska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinopathy of Prematurity (ROP)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06843720 · 7,100 participants · NA
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
- NCT00260585 · 7,000 participants
Esophageal Cancer Risk Registry
- NCT04118660 · 7,000 participants
Thoracic Specimen Registry
- NCT07106879 · 7,000 participants
Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI